Crossref
Gene Therapy Products Approved in 2022
Gene Editing · 2022
DOI: 10.29228/genediting.67056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Editing, 2022. Verfasst von Sümbül Yıldırım.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yıldırım, S. (2022). Gene Therapy Products Approved in 2022. Gene Editing. https://doi.org/10.29228/genediting.67056
Vancouver
Yıldırım S. Gene Therapy Products Approved in 2022. Gene Editing. 2022. doi:10.29228/genediting.67056
BibTeX
@article{Yldrm2022,
author = {Yıldırım, Sümbül},
title = {Gene Therapy Products Approved in 2022},
journal = {Gene Editing},
year = {2022},
doi = {10.29228/genediting.67056}
}
EUVIMED